Phase 2 failure for Innate Pharma leukaemia drug
February 6, 2017Research and Development, Sales and Marketing Innate Pharma, leukaemia, lirilumab
Lirilumab, Innate Pharma’s acute myeloid leukaemia (AML) treatment, has failed to meet its primary end point in a recent Phase …
10% of UK left with no out-of-hours GP cover during 2016
February 6, 2017Medical Communications, Sales and Marketing
A freedom of information request, by Pulse, led to the discovery that 1 in 10 areas in the UK were …
Cancer rates set to rocket in women six times faster than men
February 3, 2017Medical Communications, Research and Development Cancer, Cancer Research UK, World Cancer Day
The figures emerging from research conducted by Cancer Research UK predict that rates of cancer in women will rise by …
Takeda discusses the importance of patient-focused market access
February 3, 2017Medical Communications, Sales and Marketing Takeda, oncology
With World Cancer Day on 4 February, Takeda Oncology’s Liviu Niculescu and Stephen J. Noga talk to Pharmafile.com on the …
Top Ten most popular articles on Pharmafile.com this week
February 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
Moving into February,and the first weeks of Trump’s term, the US President has dominated the headlines in the industry as …
Study reveals antidepressant medication’s action upon brain
February 3, 2017Medical Communications, Research and Development antidepressants, mental health, research
With levels of antidepressant prescription rising coupled with the lack of development and investment in new treatments, further research into …
WCO seizes 113m fake Indian & Chinese drugs in Africa in 10 days
February 3, 2017Manufacturing and Production, Medical Communications, Sales and Marketing Africa, China, Counterfeit drugs, India, World Customs Organisation
The World Customs Organisation (WCO) has revealed insight into the extent of the global drug counterfeiting crisis with the announcement …
NICE rejects Pfizer’s first-in-class breast cancer drug
February 3, 2017Medical Communications, Sales and Marketing NICE, Pfizer, breast cancer
NICE has published draft guidelines which reject Pfizer’s Ibrance (palbociclib) based primarily on the cost of the drug but also …
Cirrus ready for serialisation pack changes
February 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cirrus, Multi Packaging Solutions
Cirrus, a Multi Packaging Solutions company, offers a full artwork management service ahead of enforced pack changes due to impending …
More at risk of sudden death due to faulty heart gene than thought
February 2, 2017Medical Communications, Research and Development British Heart Foundation, faulty gene, sudden death
The British Heart Foundation has revealed that around 620,000 people are thought to be at risk of having a faulty …
2016: A retrospective from the industry
February 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
2016 was characterised by some of the biggest political shifts in recent times. We ask four major pharma figures for …
Pakistan drug regulatory body “a complete failure” according to officials
February 2, 2017Sales and Marketing Drug Regulatory Authority of Pakistan, Pakistan, Sania Nishtar
Key figures in the Pakistani pharmaceutical industry are calling for review of the Drug Regulatory Authority of Pakistan (DRAP) over …
‘Last-resort’ antibiotic-resistant bacteria found along 4km of Chinese coastline
February 2, 2017Medical Communications, Research and Development
Recent research has been published that reveals that a four kilometre stretch of coastline in China harboured bacteria resistant to …
Allergan successfully completes $2.9bn LifeCell acquisition
February 2, 2017Business Services, Sales and Marketing Allergan, LifeCell
The acquisition of regenerative medicine firm LifeCell by Allergan for $2.9 billion announced back in December has been completely successfully, …
Two-decade-long prostate cancer study finds antiandrogen improves survival
February 2, 2017Research and Development antiandrogen, oncology, prostate cancer
Research conducted over the course of two decades has found a positive correlation between overall survival in prostate cancer patients …
Genentech oncology head leaves for Bellicum CEO role
February 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bellicum, Genentech, Roche, tecentriq
Bellicum Pharmaceuticals has snatched up Genentech’s Rick Fair as its new CEO and President. Fair moves to Bellicum from Genentech …
MSD’s drug given European approval for first-line treatment in NSCLC
February 1, 2017Sales and Marketing European Commission, MSD, Merck
The good news keeps coming for MSD, known as Merck in North America, and Keytruda, with a further label expansion …
Sanofi & Regeneron’s arthritis drug scores first approval following FDA rejection
February 1, 2017Research and Development, Sales and Marketing Actemra, Humira, Kevzara, Regeneron, Roche, Sanofi, sarilumab
Kevzara (sarilumab), a interleukin-6 (IL06) receptor antibody developed by Sanofi and Regeneron and the first real competitor to Roche’s Actemra …
Potential treatment for opioid withdrawal discovered
February 1, 2017Medical Communications, Research and Development University of Calgary, gout, opioid
Researchers from the University of Calgary have found that medication used to treat gout could also lessen the side-effects experienced …
Italian firm warned by FDA over record-shredding and drug quality misrepresentation
February 1, 2017Manufacturing and Production, Research and Development FACTA Farmaceutici, FDA
Italian drug manufacturer FACTA Farmaceutici has been issued a warning letter by the FDA after being found shredding “critical laboratory …
Latest content
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
